Molecular Inflammation Research Center for Aging Intervention (MRCA) and College of Pharmacy, Pusan National University, Busan 609-735, Korea.
Acta Pharmacol Sin. 2013 Nov;34(11):1367-73. doi: 10.1038/aps.2013.100. Epub 2013 Oct 14.
Ginseng, the root of Panax ginseng, has been used in traditional Chinese medicine as a tonic herb that provides many beneficial effects. Pharmacologic studies in the last decades have shown that ginsenosides (ginseng saponins) are primarily responsible for the actions of ginseng. However, the effects of ginseng are not fully explained by ginsenosides. Recently, another class of active ingredients called gintonin was identified. Gintonin is a complex of glycosylated ginseng proteins containing lysophosphatidic acids (LPAs) that are the intracellular lipid mitogenic mediator. Gintonin specifically and potently activates the G protein-coupled receptors (GPCRs) for LPA. Thus, the actions of ginseng are now also linked to LPA and its GPCRs. This linkage opens new dimensions for ginseng pharmacology and LPA therapeutics. In the present review, we evaluate the pharmacology of ginseng with the traditional viewpoint of Yin and Yang components. Furthermore, we will compare ginsenoside and gintonin based on the modern view of molecular pharmacology in terms of ion channels and GPCRs.
人参是五加科人参属植物,作为一种滋补草药,在中国传统医学中已有应用,具有多种有益功效。近几十年来的药理学研究表明,人参皂苷(人参皂甙)主要负责人参的作用。然而,人参的作用不能完全用人参皂甙来解释。最近,又发现了一类被称为 gintonin 的活性成分。Gintonin 是一种含有溶血磷脂酸(LPAs)的糖基化人参蛋白复合物,是细胞内脂质促有丝分裂介质。Gintonin 特异性和有效地激活 LPA 的 G 蛋白偶联受体(GPCRs)。因此,人参的作用现在也与 LPA 及其 GPCRs 有关。这种联系为人参药理学和 LPA 治疗学开辟了新的维度。在本综述中,我们用阴阳成分的传统观点来评估人参的药理学。此外,我们将根据离子通道和 GPCR 分子药理学的现代观点,比较人参皂甙和 gintonin。